Literature DB >> 8501664

A look at the statistical overview (or meta-analysis)

R R West1.   

Abstract

In essence, the statistical overview (or meta-analysis) does little more than many medical scientists and practising clinicians have been attempting for years: estimating the average size of an effect from an apparently disparate medical literature. The statistical overview provides a method of pooling the results of comparable trials (or observational studies) which, on their own, may be too small to demonstrate a 'statistically significant' effect. The role for the overview is obvious, the method is relatively simple, but the findings have to be interpreted cautiously, since joining the hypothesis post hoc contravenes one of the essential principles of scientific enquiry. The use of the statistical overview and some of its pros and cons are illustrated in four clinical examples.

Mesh:

Substances:

Year:  1993        PMID: 8501664      PMCID: PMC5396640     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


  16 in total

1.  Low molecular weight heparin.

Authors:  P A Routledge; R R West
Journal:  BMJ       Date:  1992-10-17

2.  Assessment of evidence versus consensus or prejudice.

Authors:  R West
Journal:  J Epidemiol Community Health       Date:  1992-08       Impact factor: 3.710

Review 3.  The value of lowering cholesterol after myocardial infarction.

Authors:  J E Rossouw; B Lewis; B M Rifkind
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

4.  An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.

Authors:  I Holme
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

5.  Can meta-analyses be trusted?

Authors:  S G Thompson; S J Pocock
Journal:  Lancet       Date:  1991-11-02       Impact factor: 79.321

6.  Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.

Authors:  U Ravnskov
Journal:  BMJ       Date:  1992-07-04

7.  Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

Authors:  M F Muldoon; S B Manuck; K A Matthews
Journal:  BMJ       Date:  1990-08-11

8.  Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

Authors:  M T Nurmohamed; F R Rosendaal; H R Büller; E Dekker; D W Hommes; J P Vandenbroucke; E Briët
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

9.  Report of the Conference on Low Blood Cholesterol: Mortality Associations.

Authors:  D Jacobs; H Blackburn; M Higgins; D Reed; H Iso; G McMillan; J Neaton; J Nelson; J Potter; B Rifkind
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

10.  Low molecular weight heparin in prevention of perioperative thrombosis.

Authors:  A Leizorovicz; M C Haugh; F R Chapuis; M M Samama; J P Boissel
Journal:  BMJ       Date:  1992-10-17
View more
  3 in total

1.  Librarian participation in meta-analysis projects.

Authors:  T L Mead; D T Richards
Journal:  Bull Med Libr Assoc       Date:  1995-10

2.  Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial.

Authors:  D A Jones; R R West
Journal:  BMJ       Date:  1996-12-14

Review 3.  Mega-trials: methodological issues and clinical implications.

Authors:  B G Charlton
Journal:  J R Coll Physicians Lond       Date:  1995 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.